These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 21346073)

  • 61. Surgical treatment of postoperative, incidentally diagnosed small sporadic C-cell carcinomas of the thyroid.
    Cupisti K; Simon D; Wolf A; Gerharz CD; Goretzki PE; Dotzenrath C; Witte J; Röher HD
    Langenbecks Arch Surg; 2000 Dec; 385(8):526-30. PubMed ID: 11201009
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
    Machens A; Dralle H
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2655-63. PubMed ID: 20339026
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
    Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
    Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.
    Borchhardt KA; Heinzl H; Gessl A; Hörl WH; Kaserer K; Sunder-Plassmann G
    Kidney Int; 2006 Dec; 70(11):2014-20. PubMed ID: 17051143
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
    Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
    Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
    Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Recommendation for Calcitonin Screening in Nodular Goiter].
    Frank-Raue K; Schott M; Raue F;
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1065-1069. PubMed ID: 30060274
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement.
    Bugalho MJ; Santos JR; Sobrinho L
    J Surg Oncol; 2005 Jul; 91(1):56-60. PubMed ID: 15999359
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone.
    Essig GF; Porter K; Schneider D; Debora A; Lindsey SC; Busonero G; Fineberg D; Fruci B; Boelaert K; Smit JW; Meijer JA; Duntas L; Sharma N; Costante G; Filetti S; Sippel RS; Biondi B; Topliss DJ; Pacini F; Maciel RM; Walz PC; Kloos RT
    Endocr Pract; 2013; 19(6):920-7. PubMed ID: 23757627
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Medullary thyroid carcinoma].
    Tiedje V; Ting S; Dralle H; Schmid KW; Führer D
    Internist (Berl); 2015 Sep; 56(9):1019-31. PubMed ID: 26338063
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease.
    Rink T; Truong PN; Schroth HJ; Diener J; Zimny M; Grünwald F
    Thyroid; 2009 Apr; 19(4):327-32. PubMed ID: 19355822
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Medullary thyroid carcinoma.
    Griebeler ML; Gharib H; Thompson GB
    Endocr Pract; 2013; 19(4):703-11. PubMed ID: 23512389
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Medullary thyroid carcinoma.
    Pacini F; Castagna MG; Cipri C; Schlumberger M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents.
    Eckelt F; Pfaeffle R; Kiess W; Kratzsch J
    J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1491-1504. PubMed ID: 34543539
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
    Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
    J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Latent subclinical medullary thyroid carcinoma: diagnosis and treatment.
    Henry JF; Denizot A; Puccini M; Gramatica L; Kvachenyuk A; Conte Devolx B; De Micco C
    World J Surg; 1998 Jul; 22(7):752-6; discussion 756-7. PubMed ID: 9606293
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
    McHenry CR; Oppenheim DS; Murphy T; Broughan T; Vogt D; Goldfarb WB
    Surgery; 1992 Oct; 112(4):728-32; discussion 732-3. PubMed ID: 1411944
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Incidental detection of familial medullary thyroid carcinoma by calcitonin screening for nodular thyroid disease.
    Mayr B; Brabant G; von zur Mühlen A
    Eur J Endocrinol; 1999 Sep; 141(3):286-9. PubMed ID: 10474127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.